Strategic Investment Solutions, Inc. /Il Amgen Inc Transaction History

Strategic Investment Solutions, Inc. /Il

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $1.82 Million - $2.05 Million	-7,101 Reduced 98.42%	114 $32.8 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $1.55 Million - $1.93 Million	7,101 Added 6228.95%	7,215 $1.8 Billion
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $25,740 - $31,372	114 New	114 $27.6 Million

3,056

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Strategic Investment Solutions, Inc. /Il, based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Solutions, Inc. /Il with notifications on news.